KR100676114B1 - 항암 활성을 갖는 폴리시클릭 화합물 - Google Patents

항암 활성을 갖는 폴리시클릭 화합물 Download PDF

Info

Publication number
KR100676114B1
KR100676114B1 KR1020047004899A KR20047004899A KR100676114B1 KR 100676114 B1 KR100676114 B1 KR 100676114B1 KR 1020047004899 A KR1020047004899 A KR 1020047004899A KR 20047004899 A KR20047004899 A KR 20047004899A KR 100676114 B1 KR100676114 B1 KR 100676114B1
Authority
KR
South Korea
Prior art keywords
diaza
benzo
fluoren
ethylamino
dimethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020047004899A
Other languages
English (en)
Korean (ko)
Other versions
KR20040048926A (ko
Inventor
아오야마쯔네히사
가와사끼겐이찌
마스부찌미야꼬
오쯔까다쯔오
사까따기요아끼
Original Assignee
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 호프만-라 로슈 아게 filed Critical 에프. 호프만-라 로슈 아게
Publication of KR20040048926A publication Critical patent/KR20040048926A/ko
Application granted granted Critical
Publication of KR100676114B1 publication Critical patent/KR100676114B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020047004899A 2001-10-05 2002-09-25 항암 활성을 갖는 폴리시클릭 화합물 Expired - Fee Related KR100676114B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01123908 2001-10-05
EP01123908.4 2001-10-05
PCT/EP2002/010722 WO2003031444A1 (en) 2001-10-05 2002-09-25 Polycyclic compounds having anti-tumor activity

Publications (2)

Publication Number Publication Date
KR20040048926A KR20040048926A (ko) 2004-06-10
KR100676114B1 true KR100676114B1 (ko) 2007-02-02

Family

ID=8178868

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047004899A Expired - Fee Related KR100676114B1 (ko) 2001-10-05 2002-09-25 항암 활성을 갖는 폴리시클릭 화합물

Country Status (16)

Country Link
US (1) US6680326B2 (https=)
EP (1) EP1436293B1 (https=)
JP (1) JP4369229B2 (https=)
KR (1) KR100676114B1 (https=)
CN (1) CN1284781C (https=)
AR (1) AR037327A1 (https=)
AT (1) ATE316971T1 (https=)
AU (1) AU2002342752B2 (https=)
BR (1) BR0213122A (https=)
CA (1) CA2461572C (https=)
DE (1) DE60209029T2 (https=)
ES (1) ES2256552T3 (https=)
MX (1) MXPA04003173A (https=)
PL (1) PL370530A1 (https=)
RU (1) RU2315050C2 (https=)
WO (1) WO2003031444A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946472B2 (en) * 2002-04-30 2005-09-20 Hoffman-La Roche Inc. Polycyclic compounds exhibiting anti-tumor activities
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
CN103204781B (zh) * 2013-03-14 2015-04-01 武汉大学 2,7–二取代芴酮衍生物及其制备方法与应用
CN110448555B (zh) * 2019-09-10 2020-10-23 河南省人民医院 多环化合物在制备抗肿瘤药物中的应用及抗肿瘤药物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW440562B (en) * 1994-05-20 2001-06-16 Taiho Pharmaceutical Co Ltd Condensed-indan derivative and pharmaceutically acceptable salts thereof
WO1998045272A1 (en) * 1997-04-07 1998-10-15 Latrobe University Topoisomerase inhibitors
FR2801309B1 (fr) 1999-11-18 2002-01-04 Adir Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
ES2256552T3 (es) 2006-07-16
US6680326B2 (en) 2004-01-20
CA2461572A1 (en) 2003-04-17
WO2003031444A1 (en) 2003-04-17
AR037327A1 (es) 2004-11-03
JP4369229B2 (ja) 2009-11-18
US20030073691A1 (en) 2003-04-17
CN1610681A (zh) 2005-04-27
CN1284781C (zh) 2006-11-15
PL370530A1 (en) 2005-05-30
RU2004114245A (ru) 2005-06-27
MXPA04003173A (es) 2004-07-27
CA2461572C (en) 2011-02-15
BR0213122A (pt) 2004-09-21
RU2315050C2 (ru) 2008-01-20
EP1436293A1 (en) 2004-07-14
JP2005504846A (ja) 2005-02-17
AU2002342752B2 (en) 2007-11-15
EP1436293B1 (en) 2006-02-01
DE60209029D1 (de) 2006-04-13
ATE316971T1 (de) 2006-02-15
KR20040048926A (ko) 2004-06-10
DE60209029T2 (de) 2006-09-28

Similar Documents

Publication Publication Date Title
US5061800A (en) Camptothecin derivatives
AU703041B2 (en) Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
CA2624492C (en) Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
Asobo et al. Heterocycles of biological importance. Part 5. 1 The formation of novel biologically active pyrimido [1, 2-a] benzimidazoles from allenic nitriles and aminobenzimidazoles
FI103575B (fi) Menetelmä terapeuttisesti vaikuttavien 6,9-bis(amino)bentso(g)isokinol iini-5,10-dionien valmistamiseksi
CA2205872A1 (en) Acrylamide derivatives and process for production thereof
KR100676114B1 (ko) 항암 활성을 갖는 폴리시클릭 화합물
CN114031623B (zh) 一种c14位氨基取代粉防己碱衍生物及其制备和应用
AU2002342752A1 (en) Polycyclic compounds having anti-tumor activity
RU2130937C1 (ru) 2-аминоалкил-5-аминоалкиламинозамещенные изохиноиндазол-6-(2н)-оны, способ их получения, фармацевтическая композиция и способ лечения опухоли
KR20050096970A (ko) 트리시클릭 아제핀 유도체, 이의 제조 방법 및 이를포함하는 약학적 조성물
KAWAHARA et al. Synthesis and Thermal Cyclization Reactions of Methyl Isocrotonate Derivatives
Hutchinson et al. Synthesis and properties of bioactive 2-and 3-amino-8-methyl-8H-quino [4, 3, 2-kl] acridine and 8, 13-dimethyl-8 H-quino [4, 3, 2-kl] acridinium salts
Kakehi et al. Regiospecific Formations of Thieno [3, 2-a] indolizine and Thieno [2, 3-b] indolizine Derivatives
Mastalarz et al. Synthesis and Cytostatic Properties of Some 6H‐Indolo [2, 3‐b][1, 8] naphthyridine Derivatives
CA1283411C (en) 9-(substituted thio)-4h-pyrido[1,2-a]-pyrimidin-4-one derivatives
US6946472B2 (en) Polycyclic compounds exhibiting anti-tumor activities
RU2712191C1 (ru) Противоопухолевое производное нафтоиндол-3-карбоксамида
US5604246A (en) 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones
Papageorgiou et al. Synthesis of a new heterocycle: cis-4b, 5, 6, 10b, 11, 12-hexahydro-5, 12-diazachrysene
IE920704A1 (en) Nitrogen oxides of aza- and diaza-anthracenedione¹derivatives as antitumor agents
CA1292991C (en) 4,7-dihydrothieno[2,3-b]pyridine derivatives process thereof and agents for cardiovascular diseases
US20030212061A1 (en) Aza-thioxanthenones with antitumor activity
Yadav et al. Synthesis and Antibacterial Activity of Some Novel β-Diketones/β-Ketoesters, from 4-Acetylaminobenzene Sulphonyl Chloride
ZA200502831B (en) Substituded benzol {e} {1,4} oxazino {3,2-G} isoindole derivatives, method for preparing same and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20111228

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20121227

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20140125

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20140125

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000